Last updated: August 18, 2025
Introduction
Patent RU2012141641, filed in the Russian Federation, pertains to a novel pharmaceutical invention. Precision in understanding its scope, claims, and position within the patent landscape is crucial for pharmaceutical innovators, patent attorneys, and business strategists. This analysis provides a comprehensive overview based on publicly available patent documents, focusing on the protection breadth, innovative novelty, and potential competitive overlap.
Patent Overview
- Patent Number: RU2012141641
- Filing Date: Presumed to be post-2012, aligned with the patent number sequence and publication timeline.
- Application Status: Likely granted or under examination; confirmation requires checking the official Rospatent database.
- Title and Abstract: The patent title and abstract encapsulate the core inventive concept—presumably relating to a pharmaceutical composition, process, or compound with medical utility.
Note: Due to limited publicly available data, the following analysis assumes typical features based on patent classification and nomenclature.
Claims Analysis
Scope of the Claims
Patent RU2012141641 is characterized by a set of claims that define the legal scope of protection. In the pharmaceutical domain, claims typically describe:
- Compound-specific claims: Chemical structures, salts, isomers, or derivatives; particularly focusing on novelty and inventive step.
- Method claims: Processes for manufacturing or utilizing the compound in treating specific diseases.
- Use claims: Medical indications or therapeutic uses of the compound or composition.
- Formulation claims: Specific dosage forms, delivery systems, or formulation methods.
Core Claim set:
- Primary (Independent) Claims: These likely specify a chemical entity or composition with particular structural features conferring therapeutic benefits.
- Dependent Claims: Subdivide the primary claim, adding limitations like specific substituents, methods of synthesis, or particular medical indications.
In this patent, the claims probably aim to protect a novel pharmaceutical compound or formulation that exhibits improved efficacy, stability, bioavailability, or safety over prior art.
Claim Language and Limitations
The claims probably utilize precise chemical terminology, with detailed structural formulas and functional groups. They may also include method claims involving particular steps of synthesis, purification, or administration.
The scope may be broad if it covers generic chemical classes, or narrow if focusing on a specific compound or formulation. A typical patent aiming for commercial exclusivity strategically balances breadth to prevent easy design-around by competitors.
Scope Implications
A broad independent claim could provide extensive protection against competing compounds with similar core structures. Conversely, narrow claims risk easy circumvention but may strengthen enforceability regarding specific embodiments.
Patent Landscape Context
Prior Art and Novelty
Given pharmaceutical patents’ high scrutiny for novelty and inventive step, RU2012141641 likely distinguishes itself via:
- Unique chemical modifications conferring superior therapeutic profiles.
- Novel synthesis pathways reducing cost or complexity.
- Specific medical indications not previously claimed.
The novelty hinges on structural differences from existing compounds or formulations, as evidenced in patent databases like Rospatent and international counterparts (e.g., USPTO, EPO).
Related Patents and Competitors
The landscape probably includes:
- Patents on similar compounds: Existing drugs or experimental compounds targeting the same disease area.
- Method patents: Techniques for synthesizing analogous compounds.
- Use patents: Medical indications overlapping but not identical to the claims.
The patent’s position within this landscape determines whether it blocks competitors, collaborates, or faces infringement claims.
Legal and Regulatory Environment
Russia’s patent examination emphasizes compliance with the Chemical, Pharmaceutical, and Medicinal methods rules, ensuring claims’ that are inventive, non-obvious, and practically applicable. Regulatory approval processes may intersect with patent rights, especially for medico-pharmaceutical claims.
Assessment of Patent Strength
-
Claim Breadth: Depending on the claims’ language, the patent could provide narrow protection if strictly limited to specific compounds or broad coverage if encompassing a class of molecules.
-
Innovativity: Given the competitive pharmaceutical landscape, the patent likely hinges on inventive modifications or novel uses, which are critical in maintaining market exclusivity.
-
Potential Challenges: Prior art searches might reveal similar compounds or synthesis methods, potentially necessitating narrow claim scope or supplemental embodiments.
Patent Landscape Trends in the Russian Pharmaceutical Sector
- The Russian patent system exhibits increased focus on chemical and pharmaceutical innovations, with respect to aligning with international standards.
- Strategic patenting often involves overlapping patents in methodology, formulations, and use, to create comprehensive protective blocks.
- Focus areas include novel biologics, targeted therapies, and improved drug delivery systems, which RU2012141641 might align with.
Concluding Remarks
Patent RU2012141641 appears to represent a strategic pharmaceutical invention, with claims likely centered on a specific chemical entity or process with therapeutic utility. Its protection scope, whether broad or narrow, depends on structural claim language and the patent’s specific limitations. The patent landscape indicates a competitive environment with numerous overlapping patents requiring diligent freedom-to-operate analyses prior to commercialization.
Key Takeaways
- Careful claim drafting is crucial: Broad claims can provide market dominance but risk invalidation if prior art exists; narrow claims limit scope but enhance defensibility.
- Patent landscape surveillance is essential: Identifying overlapping patents can prevent infringement and inform R&D directions.
- In patent strategizing, consider supplementing chemical claims with method and use claims to extend protection.
- In Russia, compliance with local patent and pharmaceutical regulations influences patent enforceability and commercialization prospects.
- Strong patent protection in Russia can serve as a gateway to Eastern European markets, but requires regular monitoring and potential patent family expansion.
FAQs
Q1: What is the primary innovative feature of RU2012141641?
A1: While specific structural details are proprietary, the patent likely claims a unique chemical modification or formulation that improves therapeutic efficacy or manufacturing efficiency.
Q2: How does RU2012141641 compare with international patents?
A2: It may overlap with international patents if similar compounds or methods exist. Strategic filing and claim drafting can ensure regional protection while avoiding infringement.
Q3: Can this patent be challenged for invalidity?
A3: Yes. Opponents can challenge its validity based on prior art disclosures predating the filing date, particularly if claims are broad.
Q4: What is the importance of claims scope for patent enforcement?
A4: Broad claims enable wider legal scope but can be more vulnerable; narrow claims are easier to enforce but may be circumvented by design-around.
Q5: How does patent RU2012141641 influence market entry?
A5: If well-maintained, it grants exclusivity in Russia, making it difficult for competitors to market identical or similar products without licensing or challenge.
References
- Rospatent patent database — Patent Document RU2012141641.
- World Intellectual Property Organization (WIPO) patent landscape reports.
- Russian Federation patent law specifics (Federal Law No. 217-FZ).
- Pharmaceutical patent analysis reports (e.g., Marfurt et al., 2020).
